October 1, 2025
Pfizer arrives in agreement with Trump to reduce Medicaid drug prices, prevent invoices
PFIZER (PFE.N) and President Donald Trump said they had reached an agreement on the basis of which the US -based pharmacist agreed to reduce the prices of drug prescription prices in the Medicaid program to match those charged to other developed countries in return for relief. Trump also said Pfizer would offer that the most favorable pricing of the national spot in all new drugs that started in the US and said other pharmacists would follow their example. Pfizer’s shares rose more than 6% on Tuesday, and the news uploaded Eli Lilly (Lly.n), Merck (mrk.n), AMGEN (AMGN.O), ABBVIE (ABBV.N) and




